Carolyn Berg is Vice-President, Business Development at Catalent and has over 25 years of experience in pharmaceutical sales, marketing and business development.

She is currently Vice-President, Business Development for Catalent’s inhaled drug delivery solutions, where she is responsible for growing the inhalation business in North America and Europe. Prior to Catalent, Ms Berg held various leadership roles within Cipla, Teva Respiratory and Merck, and owned her own consulting practice for pharmaceutical and healthcare clients. Ms Berg holds a Bachelor’s degree in Journalism in Public Relations and another in French from the University of Texas at Austin (TX, US), as well as an MBA from the University of South Carolina (SC, US).